Financial Results : Al-Modawat H1 2025 net profit up 227% to SAR 10.3M

Al-Modawat H1 2025 net profit up 227% to SAR 10.3M

03/08/2025 Argaam Exclusive

View other reports

Al-Modawat Specialized Medical Co.’s net profit rose 227% to SAR 10.3 million in the first half of 2025, compared to SAR 3.2 million in the prior-year period.



Current Half Annual Comparison (M)

Compared With The
Item H1 2024 H1 2025 Change‬
Revenues 37.29 55.22 48.1 %
Gross Income 17.33 25.70 48.3 %
Operating Income 3.79 11.22 196.3 %
Net Income 3.16 10.35 227.4 %
Average Shares 71.25 71.25 -
Earnings Per Share before unusual items (Riyal) 0.04 0.15 227.4 %
EPS (Riyal) 0.04 0.15 227.4 %

The healthcare services provider noted an increase in the number of patients after the commissioning of the first expansion and improvement in services.

 

Sequentially, net profit grew 255.4% from SAR 2.91 million in H2 2024.

 

Shareholders’ equity, no minority interest, rose to SAR 86.98 million as of June 30, 2025, from SAR 78.51 million a year earlier.

View More Financial Results

 


Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 - - - - - -
H2 2020 - - - - - -
H1 2021 - - - - - -
H2 2021 - - - - - -
H1 2022 25.30 - 11.91 - 4.05 -
H2 2022 33.26 - 16.61 - 7.40 -
H1 2023 37.18 46.9 % 21.40 79.8 % 11.52 184.6 %
H2 2023 37.13 11.6 % 19.23 15.8 % 8.65 17.0 %
H1 2024 37.29 0.3 % 17.33 (19.0 %) 3.79 (67.1 %)
H2 2024 38.20 2.9 % 13.68 (28.8 %) 3.78 (56.3 %)
H1 2025 55.22 48.1 % 25.70 48.3 % 11.22 196.3 %


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS(Riyal)
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 - - - - - -
H2 2020 - - - - - -
H1 2021 - - - - - -
H2 2021 - - - - - -
H1 2022 3.64 - 0.06 - 3.64 0.06
H2 2022 6.67 - 0.12 - 6.67 0.12
H1 2023 10.93 200.4 % 0.19 - 10.93 0.19
H2 2023 7.66 14.8 % 0.13 - 7.66 0.13
H1 2024 3.16 (71.1 %) 0.04 - 3.16 0.04
H2 2024 2.91 (62.0 %) 0.04 - 2.91 0.04
H1 2025 10.35 227.4 % 0.15 - 10.35 0.15

Profitability

Period Gross Margin Adjusted EBITDA margin Net Margin Before Unusual Items
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 - - -
H1 2022 - - -
H2 2022 48.69 % 22.19 % 17.61 %
H1 2023 53.96 % 30.58 % 25.00 %
H2 2023 54.67 % 32.07 % 25.02 %
H1 2024 49.12 % 22.40 % 14.54 %
H2 2024 41.08 % 17.77 % 8.05 %
2024 41.08 % 17.77 % 8.05 %
H1 2025 42.15 % 24.09 % 14.20 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Earnings Per Share before unusual items (Riyal) Book Value (BV)
H1 2016 - - - -
H2 2016 - - - -
H1 2017 - - - -
H2 2017 - - - -
H1 2018 - - - -
H2 2018 - - - -
H1 2019 - - - -
H2 2019 - - - -
H1 2020 - - - -
H2 2020 - - - -
H1 2021 - - - -
H2 2021 - - - -
H1 2022 57.00 - - 0.40
H2 2022 57.00 0.18 0.18 0.54
H1 2023 57.00 0.31 0.31 0.65
H2 2023 57.00 0.33 0.33 0.69
H1 2024 71.25 0.15 0.15 1.10
H2 2024 71.25 0.09 0.09 1.08
H1 2025 71.25 0.19 0.19 1.22

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Recurring P/E Price/book
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 - - -
H1 2022 - - -
H2 2022 - - -
H1 2023 - - -
H2 2023 - - -
H1 2024 33.35 33.35 4.60
H2 2024 66.47 66.47 5.23
H1 2025 36.53 36.53 5.57

Business Segments (Million)

Compared With The
Period Medical Services Pharmaceutical Products Other
H1 2022 23.69 1.61 -
H2 2022 31.82 1.44 -
H1 2023 35.50 1.67 -
H2 2023 35.40 1.73 -
H1 2024 35.27 2.01 -
H2 2024 34.88 2.55 0.78
H1 2025 50.55 2.83 1.83


Financial Ratios
Current
Market Cap (M Riyal) 290.70
Enterprise Value (EV) (M Riyal) 305.18
Shares Outstanding ((M)) 71.25
Book Value (BV) ( Riyal) 1.24
Par Value ( Riyal) 1.00
Recurring P/E 15.32
Price/book 3.29
EV/adj EBITDA 10.08
EV/Revenues 2.51
more

Share Price

Al-Modawat Specialized Medical Co.
4.08
0.13 3.29 %

Al-Modawat Specialized Medical Co. (ALMODAWAT)

More

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.